Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 113(8): 1805-8, 2009 Feb 19.
Article in English | MEDLINE | ID: mdl-18955558

ABSTRACT

Hereditary forms of iron-deficiency anemia, including animal models, have taught us much about the normal physiologic control of iron metabolism. However, the discovery of new informative mutants is limited by the natural mutation frequency. To address this limitation, we have developed a screen for heritable abnormalities of red blood cell morphology in mice with single-nucleotide changes induced by the chemical mutagen ethylnitrosourea (ENU). We now describe the first strain, fragile-red, with hypochromic microcytic anemia resulting from a Y228H substitution in the ferrireductase Steap3 (Steap3(Y288H)). Analysis of the Steap3(Y288H) mutant identifies a conserved motif required for targeting Steap3 to internal compartments and highlights how phenotypic screens linked to mutagenesis can identify new functional variants in erythropoiesis and ascribe function to previously unidentified motifs.


Subject(s)
Anemia, Iron-Deficiency/genetics , Anemia, Iron-Deficiency/metabolism , Iron/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Anemia, Iron-Deficiency/physiopathology , Animals , Cell Cycle Proteins , Cell Line , Endosomes/metabolism , FMN Reductase/metabolism , Gene Library , Genetic Testing/methods , Humans , Kidney/cytology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mutagenesis , Oxidoreductases
2.
Biometals ; 20(1): 43-7, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16688476

ABSTRACT

The chewing of areca nut is associated with the development of oral submucous fibrosis (OSF), a condition predominantly encountered in Asians indulging in the habit. The pathogenesis of this condition is however, unclear, though several mechanisms have been proposed. Copper has previously been implicated as a possible aetiological factor. In this study, total copper concentration was measured via atomic absorption spectrophotometry in whole mouth saliva of 15 volunteers who were regular chewers, before and after their habitual chew. An aliquot of the latter was also analysed for copper. Six non-chewing volunteers acted as controls. Salivary copper concentrations were corrected for protein content. Over 50% of the subjects had basal salivary copper concentration higher than the range seen in normal controls. All but two subjects demonstrated an increase in the salivary [Cu] following their habitual chew. Marked changes were seen in those with low basal salivary concentrations. These data indicate that soluble copper found in areca nut is released into the oral environment of habitual chewers. Its buccal absorption may contribute to the oral fibrosis in Asians who regularly chew this nut.


Subject(s)
Areca/chemistry , Copper/metabolism , Nuts/chemistry , Saliva/metabolism , Adolescent , Adult , Copper/analysis , Humans , Male , Mastication , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/pharmacology , Saliva/drug effects , Spectrophotometry, Atomic
3.
Biometals ; 19(5): 547-53, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16937261

ABSTRACT

Absorption from food is an important route for entry of the toxic metal, cadmium, into the body. Both cadmium and iron are believed to be taken up by duodenal enterocytes via the iron regulated, proton-coupled transporter, DMT1. This means that cadmium uptake could be enhanced in conditions where iron absorption is increased. We measured pH dependent uptake of (109)Cd and (59)Fe by duodenum from mice with an in vitro method. Mice with experimental (hypoxia, iron deficiency) or hereditary (hypotransferrinaemia) increased iron absorption were studied. All three groups of mice showed increased (59)Fe uptake (p<0.05) compared to their respective controls. Hypotransferrinaemic and iron deficient mice exhibited an increase in (109)Cd uptake (p<0.05). Cadmium uptake was not, however, increased by lowering the medium pH from 7.4 to 6. In contrast, (59)Fe uptake (from (59)FeNTA(2)) and ferric reductase activity was increased by lowering medium pH in control and iron deficient mice (p<0.05). The data show that duodenal cadmium uptake can be increased by hereditary iron overload conditions. The uptake is not, however, altered by lowering medium pH suggesting that DMT1-independent uptake pathways may operate.


Subject(s)
Cadmium/metabolism , Duodenum/metabolism , Intestinal Absorption/physiology , Iron Metabolism Disorders/metabolism , Iron/metabolism , Transferrin/deficiency , Animals , Cadmium Radioisotopes/metabolism , Hydrogen-Ion Concentration , Iron Metabolism Disorders/genetics , Iron Radioisotopes/metabolism , Male , Mice
4.
Br J Haematol ; 131(5): 656-62, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16351643

ABSTRACT

The regulation of intestinal iron absorption is not fully understood. Hepcidin, a liver-produced peptide, has recently been identified as a negative regulator of iron absorption in various conditions associated with altered iron metabolism (e.g. inflammation, anaemia, hypoxia). It is not clear whether these perturbants share a common signalling pathway. In this study, the importance of the cytokine interleukin-6 (IL-6) was investigated in the hypoxic mouse model. Hypoxia was associated with increased levels of circulating IL-6, decreased liver hepcidin mRNA and increased iron absorption (especially MT). A significant positive correlation existed between the total iron uptake and IL-6 levels in circulation. IL-6 per se, though inducing hepcidin mRNA, failed to affect basal iron absorption. The adaptive response to absorption following the hypoxic exposure was, however, more prominent if mice had been treated concurrently with IL-6. This enhancement in absorption occurred even though hepcidin mRNA was not significantly changed. Similar prominent responses were seen with both human and mouse IL-6. Anti-IL-6 antiserum normalised iron absorption in mice exposed to hypoxia, because of a reduction in the MT. These data indicate that IL-6 can influence iron absorption (especially MT) during the hypoxic exposure, but via a mechanism independent of hepcidin.


Subject(s)
Duodenum/metabolism , Hypoxia/immunology , Interleukin-6/physiology , Intestinal Absorption/immunology , Iron/metabolism , Animals , Antimicrobial Cationic Peptides/analysis , Hepcidins , Interleukin-6/analysis , Interleukin-6/genetics , Isotope Labeling , Male , Mice , Mice, Inbred Strains , Models, Animal , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
5.
Basic Clin Pharmacol Toxicol ; 94(4): 161-8, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15078340

ABSTRACT

The relationship between haem biosynthesis and intestinal iron absorption in mice was investigated by ascertaining the effect of the haem synthesis inhibitor, griseofulvin, on duodenal iron absorption using both in vivo and in vitro measurements. Urinary 5-aminolaevulinic acid levels were increased within 24 hr of feeding mice with griseofulvin diet (2.5% w/w), with more marked increases seen after 3-7 days. Urinary porphobilinogen levels also showed a similar trend. In vivo intestinal iron absorption was significantly reduced (P<0.05) in experimental mice, mainly due to reduction in the transfer of 59Fe from the enterocytes to the portal circulation. In vitro studies using isolated duodenal fragments also exhibited marked decreases in both iron uptake and Fe (III) reduction. Changes in mucosal Divalent Metal Transporter 1 (DMT-1), Dcytb and Ireg1 (iron regulated protein 1) mRNA levels paralleled the changes in iron absorption. The reduction in iron absorption after griseofulvin treatment was normalised when mice were simultaneously injected with haem-arginate. These data support the hypothesis that intermediates in haem biosynthesis, particularly 5-aminolaevulinic acid, regulate intestinal iron absorption.


Subject(s)
Griseofulvin/pharmacology , Heme/antagonists & inhibitors , Intestinal Absorption/drug effects , Iron, Dietary/pharmacokinetics , Administration, Oral , Aminolevulinic Acid/urine , Animals , Biological Transport/drug effects , Body Weight/drug effects , Cation Transport Proteins/biosynthesis , Cation Transport Proteins/genetics , Drug Interactions , Duodenum/metabolism , Gene Expression/drug effects , Heme/biosynthesis , In Vitro Techniques , Iron-Binding Proteins/biosynthesis , Iron-Binding Proteins/genetics , Liver/metabolism , Liver/physiology , Male , Mice , Organ Size/drug effects , Porphobilinogen/urine
6.
Pharmacol Toxicol ; 91(3): 97-102, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12427107

ABSTRACT

Recent advances in cloning of proteins involved in intestinal iron absorption can inform design and understanding of therapeutic iron preparations. Redox chemistry of iron is particularly important in iron metabolism, both as a potential source of toxic intermediates and as an essential requirement for efficient iron transport. The initial step in iron absorption (uptake from lumen to mucosa) is particularly important and several pathways involving Fe(III) reduction or transport and Fe(II) transport have been identified. Novel genes associated with iron uptake include Dcytb, a putative iron-regulated reductase and DMT1, a Fe(II) carrier in the brush border membrane. Other mechanisms may also operate, however. We review the recent findings and apply this to understanding the absorption of Fe(III) pharmaceuticals.


Subject(s)
Iron , Animals , Humans , Intestinal Absorption , Intestinal Mucosa/metabolism , Iron/chemistry , Iron/metabolism , Iron/pharmacokinetics , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...